Translate
Violation Detail
Standard Cited: 19100134 D01 III Respiratory Protection.
This violation item has been deleted.
Inspection Nr: 1440581.015
Citation: 01001
Citation Type: Serious
Abatement Status:
Initial Penalty: $5,114.00
Current Penalty: $0.00
Issuance Date: 11/12/2019
Nr Instances: 1
Nr Exposed: 1
Abatement Date: 12/09/2019
Gravity: 5
Report ID: 0418100
Contest Date:
Final Order: 12/09/2019
Related Event Code (REC): R
Emphasis:
| Type | Latest Event | Event Date | Penalty | Abatement Due Date | Citation Type | Failure to Abate Inspection |
|---|---|---|---|---|---|---|
| Penalty | I: Informal Settlement | 12/09/2019 | $0.00 | 12/09/2019 | Serious | |
| Penalty | Z: Issued | 11/12/2019 | $5,114.00 | 12/09/2019 | Serious |
Text For Citation: 01 Item/Group: 001 Hazard:
29 CFR 1910.134(d)(1)(iii): The employer did not identify and evaluate the respiratory hazard(s) in the workplace; including a reasonable estimate of employee exposures to respiratory hazards and identification of the contaminant's chemical state and physical form: Noramco Inc., Athens, GA - On or about October 16, 2019, an employee was recording data and entering the area where the milling of Buprenorphine Hydrochloride was being conducted, to check the testing process. An evaluation of the respiratory hazard for the employee recording data and checking the process was not performed resulting in an exposure to Buprenorphine Hydrochloride that resulted in a hospitalization of the employee.